Drugs / 90Y DOTATATE
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04029428 Comparator | Nov 2004 → Jan 2021 | neuroendocrine neoplasm | University of Warmia and Mazury | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 90Y DOTATATE | “Total activity of 90Y DOTATATE, 4x3.7GBq (14.8 GBq). Single session of i.v. infusion of 90Y DOTATATE administered for 20 min via infusion pump with co-infusion of amino-acids...” NCT04029428 ↗ |
| Route | Intravenous | “Single session of i.v. infusion of 90Y DOTATATE administered for 20 min via infusion pump” NCT04029428 ↗ |